Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma

Clinical trial NCT01418495 · COMPLETED

Trial details

NCT number: NCT01418495
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Study type: OBSERVATIONAL

Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Neurotoxicity Syndrome Pain Regional Neuroblastoma Stage 4 Neuroblastoma Stage 4S Neuroblastoma

Start date: 2011-05-26
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.